We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
+13.93%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$279M
AUM Growth
-$78M
(-22%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-40.91%
Top 10 Holdings %
Top 10 Hldgs %
73.01%
Holding
25
New
–
Increased
–
Reduced
6
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$98.5M |
| 2 |
Dynatrace
DT
|
+$8.06M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$4.72M |
| 4 |
S&P Global
SPGI
|
+$1.3M |
| 5 |
Visa
V
|
+$901K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.01% |
| 2 | Financials | 13.2% |
| 3 | Consumer Discretionary | 8.69% |
| 4 | Consumer Staples | 4.47% |
| 5 | Communication Services | 4.47% |
Similar funds
VM
SCP
SSC
I
SCMS
ACM
MCM
MIA
Howard Hughes Medical Institute's Q4 2019 Portfolio in Review
As of Q4 2019, Howard Hughes Medical Institute held 25 positions worth $279M, down 22% from $357M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Howard Hughes Medical Institute withdrew a net $114M in Q4 2019, reducing 6 holdings. Its largest reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $98.5M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Howard Hughes Medical Institute's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $98.5M.
- Howard Hughes Medical Institute's ten largest holdings make up 73% of its $279M portfolio in Q4 2019.
- Howard Hughes Medical Institute opened 0 new positions and closed 0 in Q4 2019.
- Howard Hughes Medical Institute's portfolio value fell 22% quarter-over-quarter to $279M.
Based on Howard Hughes Medical Institute's 13F filing for Q4 2019, filed 12 Feb 2020.